1 ML canakinumab 150 MG/ML Injection [Ilaris]
- RxCUI
- 1864326
- RxNorm name
- 1 ML canakinumab 150 MG/ML Injection [Ilaris]
- Display name
- 1 ML canakinumab 150 MG/ML Injection [Ilaris]
- Full name
- 1 ML canakinumab 150 MG/ML Injection [Ilaris]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125319 | Ilaris | canakinumab | 351(a) | Disc | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ilaris | CANAKINUMAB | Novartis Pharmaceuticals Corporation | 7d271f3b-e4f9-4d80-8dcf-28d49123f80e | 2026-06-08 | Warnings, Adverse reactions | 1864326 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7d271f3b-e4f9-4d80-8dcf-28d49123f80e | 1 ML canakinumab 150 MG/ML Injection [Ilaris] | SBD | 30 | These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009 | 20250618 |
| 7d271f3b-e4f9-4d80-8dcf-28d49123f80e | 1 ML Ilaris 150 MG/ML Injection | SY | 30 | These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009 | 20250618 |
| 7d271f3b-e4f9-4d80-8dcf-28d49123f80e | ILARIS 150 MG in 1 ML Injection | PSN | 30 | These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009 | 20250618 |
| 7d271f3b-e4f9-4d80-8dcf-28d49123f80e | Ilaris 150 MG per 1 ML Injection | SY | 30 | These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS ® (canakinumab) injection, for subcutaneous use Initial U.S. Approval: 2009 | 20250618 |